CatSci Ltd is an award-winning innovation partner, dedicated to breaking down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients. We proudly serve customers across the globe with projects, meeting their needs from candidate selection to product launch and beyond. Our tailored services include route scouting and selection, initial scale-up and risk management for early development. For later development, we provide process design, assessment and optimisation, scale-up for clinical and commercial manufacture, tech transfer and post-approval improvements.
We possess a range of critical enabling technologies in research, development and manufacturing of small molecule and new modality therapeutics, with specialist facilities in chemical development, catalysis, material science, pre-formulation, HPAPI development, GMP analytical services, and oligonucleotide R&D and supply. Through our partnership with AGC Pharma Chemicals, we offer scalable small molecule API manufacturing, from grams to tonnes, with complete accountability of tech transfer.
Agile, commercially minded and scientifically led, CatSci leverages its highly qualified technical team and state-of-the-art facilities to empower our customers to create affordable, best-in-class therapeutics in a safer, greener and more cost-effective way. Together, we can meet the evolving healthcare needs of the world.
Recent recognition includes the 2024 Finance Awards Wales (ESG Excellence), the 2023 UK Fast Growth 50 Index Award (Innovative Growth), the Queen’s Award for Enterprise: International Trade 2022, the 2022 Bionow Awards (Export of the Year), the 2022 Inspire Business Awards (Business of the Year (25+ employees)), the 2022 Wales Business Awards (Workplace Wellbeing), the 2022 Wales STEM Awards (STEM Company of the Year (50+ Employees), and the 2022 Cardiff Business Award (International Business of the Year).
Company Details
- Employees
- 107
- Founded
- -
- Address
- Cbtc2, Capital Business Park, Wentloog,cardiff,cf3 2px,united Kingdom
- Phone
- +44 29 2083 7444
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- catsci.com
- Keywords
- New route design and development, Chemical development & scale-up, Biocatalysis, Chemocatalysis, Metal removal, recovery & recycle, Training & consultancy, Custom synthesis, Material science, Analytical development, Route scouting & selection, Risk management, Process design, assessment and optimisation, Tech transfer, Post-approval improvements, Green chemistry, Model-led exploration of design space for process definition, Material Science, Formulation Development, TACS, Glues, Oligonucleotides, GMP-analytical services, HPAPIs, Catalysis screening & optimisation, Solid-state, Crystallisation, preformulation, process development, Oligo synthesis and analysis, separation science, chromatography.
- HQ
- Wentloog, Cardiff,
Catsci Ltd Questions
Catsci Ltd's helpline number is +44 29 2083 7444
Catsci Ltd's website is catsci.com
Catsci Ltd's LinkedIn profile is https://uk.linkedin.com/company/catsci-ltd
Catsci Ltd has
107 employees.
View email and phone details for 107
employees at Catsci Ltd.
Catsci Ltd's industry is
Pharmaceutical Manufacturing
Catsci Ltd's top competitors are
Gsk,
Astrazeneca,
Reach Separations,
Lablinks,
Pharmaron,
Exactmer,
Evotec,
Charnwood Discovery, Part Of Concept Life Sciences,
Concept Life Sciences,
Sygnature Discovery.
Catsci Ltd's categories are Pharmaceutical Manufacturing
Catsci Ltd's founding year is 2010
